Overall, these results indicate that the infusion of antibodies, which block HSP70 or GRP78, reversed the histological and molecular features of NASH, potentially mimicking the effects of DJB. The gene discussed is HSPA5; the disease is metabolic dysfunction-associated steatohepatitis.